findmyKOL
Clinical trialNCT00076063CompletedPhase 1/PHASE2Interventional

A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment174HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will test the immune system response to and safety of two HIV vaccines alone and in combination: ALVAC-HIV (vCP1452) and LIPO-5. ALVAC-HIV (vCP1452) uses a canarypox virus with man-made parts of HIV attached to it. The canarypox virus cannot cause disease in people. LIPO-5 is a mixture of five man-made proteins similar to proteins found in HIV. These vaccines are not produced from live HIV or from infected cells and do not contain the virus. It is not possible to become infected with HIV from these vaccines.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Alabama Vaccine Crs

    Birmingham, Alabama, United States

  • Johns Hopkins Bloomberg School of Public Health,ctr for Immunization Research,project Save-Baltimore

    Baltimore, Maryland, United States

  • Project Brave Hiv Vaccine Crs

    Baltimore, Maryland, United States

  • Brigham and Women'S Hosp. Crs

    Boston, Massachusetts, United States

  • Fenway Community Health Clinical Research Site (fchcrs)

    Boston, Massachusetts, United States

  • Saint Louis Univ. School of Medicine, Hvtu

    St Louis, Missouri, United States

  • Univ. of Rochester Hvtn Crs

    Rochester, New York, United States

  • Ny Blood Ctr./bronx Crs

    The Bronx, New York, United States

  • Miriam Hospital'S Hvtu

    Providence, Rhode Island, United States

  • Vanderbilt Vaccine Crs

    Nashville, Tennessee, United States

  • Fhcrc/uw Vaccine Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ALVAC-HIVLIPO-5
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2004
Primary completion
—
Completion
31 Mar 2007
Last update posted
14 Oct 2021
Registered enrollment
174
Registry id
NCT00076063
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.